Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Starting at a lower dose and increasing gradually gives your body time to adapt
ZBTB1 regulates asparagine synthesis and leukemia cell response to L-asparaginase
This helps it get absorbed better
Without adequate nitric oxide, blood vessels become stiffer, resistance increases, and the heart has to work harder to push blood through the system
Kwon HJ, Lee KL, Lee SI, et al
Research-grade specs Components: CJC-1295 No DAC (GHRH analog) + Ipamorelin (GHSR ligand) 5 MG vial: CJC-1295 5 mg + Ipamorelin 5 mg (10 mg total) 10 MG vial: CJC-1295 10 mg + Ipamorelin 10 mg (20 mg total) CJC-1295 length: 30 amino acids Half-life: ~30 minutes for the No DAC variant, reported in published literature Format: Lyophilized powder, single-vial blend Studied applications GHRH + GHRP receptor-pathway synergy research Pulsatile GH-release studies Comparative research vs the CJC-1295 With DAC variant Receptor-selectivity comparison against each compound alone Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
US$ 29.13
US$ 22.27
US$ 27.99
US$ 22.09
US$ 20.75
US$ 22.37
US$ 20.44
US$ 29.69
US$ 24.23
US$ 25.02
